Holen Sie sich die Stockscreener-App
16.04
3.61%
-0.58
Schlusskurs vom Vortag:
$16.62
Offen:
$16.43
24-Stunden-Volumen:
378.71K
Relative Volume:
0.40
Marktkapitalisierung:
$651.05M
Einnahmen:
$128.29M
Nettoeinkommen (Verlust:
$-30.69M
KGV:
-19.56
EPS:
-0.82
Netto-Cashflow:
$-27.17M
1W Leistung:
+21.00%
1M Leistung:
+12.82%
6M Leistung:
-64.44%
1J Leistung:
-74.31%
1-Tages-Spanne:
$15.95
$16.68
1-Wochen-Bereich:
$13.00
$16.74
52-Wochen-Spanne:
$12.53
$64.50
Rxsight Inc Stock (RXST) Company Profile
Firmenname
Rxsight Inc
Sektor
Branche
Telefon
949-521-7822
Adresse
100 COLUMBIA STREET, ALISO VIEJO
Vergleichen Sie RXST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
16.02 | 536.41M | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
134.16 | 224.53B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
105.59 | 152.31B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
382.00 | 148.10B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
85.54 | 109.16B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.90 | 44.29B | 5.54B | 4.18B | 623.10M | 7.00 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-19 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | Eingeleitet | Piper Sandler | Neutral |
| 2025-04-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-04-04 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2025-04-03 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-12-20 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-11 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | Eingeleitet | UBS | Buy |
| 2024-10-29 | Eingeleitet | Jefferies | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-08-06 | Bestätigt | Needham | Buy |
| 2024-05-07 | Bestätigt | BTIG Research | Buy |
| 2023-12-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-12-12 | Eingeleitet | Stifel | Buy |
| 2023-12-04 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-04-13 | Eingeleitet | Oppenheimer | Outperform |
| 2022-12-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-08 | Eingeleitet | Needham | Buy |
Alle ansehen
Rxsight Inc Aktie (RXST) Neueste Nachrichten
RxSight, Inc. (NASDAQ:RXST) Given Consensus Recommendation of “Hold” by Brokerages - Defense World
RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum - GlobeNewswire
RxSight Showcases Cataract Surgery Innovation at Major Ophthalmology Conference - Stock Titan
Wells Fargo Upgrades RxSight (RXST), Sees LAL Technology as Undervalued - MSN
RxSight (NASDAQ:RXST) Upgraded to Overweight at Wells Fargo & Company - Defense World
RxSight Shares Rise After Upgrade From Wells Fargo - marketscreener.com
Deep Dive Into RxSight Stock: Analyst Perspectives (13 Ratings) - Benzinga
Wells Fargo Upgrades RxSight (RXST) - Nasdaq
Wells Fargo Upgrades RxSight to Overweight From Equalweight, Lifts Price Target to $25 From $17 - marketscreener.com
Wells Fargo lifts RxSight stock rating, raises target to $25 By Investing.com - Investing.com India
Wells Fargo lifts RxSight stock rating, raises target to $25 - Investing.com
RxSight (RXST) Receives Upgrade from Wells Fargo with Increased Price Target | RXST Stock News - GuruFocus
Wells Fargo upgrades RxSight on ‘strong first-mover advantage’ - TipRanks
RxSight Inc (RXST) Stock Price Up 5.15% on May 16 - GuruFocus
Midday Stock Roundup: RxSight Up 13% on Wells Fargo Upgrade - Orange County Business Journal
Northern Trust Corp Raises Stock Holdings in RxSight, Inc. (NASDAQ:RXST) - Defense World
Rxsight at Bank of America Conference: Strategic Shifts Amid Challenges By Investing.com - Investing.com Nigeria
Transcript : RxSight, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 03 - marketscreener.com
Rxsight at Bank of America Conference: Strategic Shifts Amid Challenges - Investing.com Australia
Price T Rowe Associates Inc. MD Sells 23,863 Shares of RxSight, Inc. (NASDAQ:RXST) - Defense World
Morgan Stanley Adjusts Price Target on RxSight to $20 From $42, Maintains Overweight Rating - marketscreener.com
RxSight, Inc. (NASDAQ:RXST) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance
Dimensional Fund Advisors LP Acquires 237,877 Shares of RxSight, Inc. (NASDAQ:RXST) - Defense World
Insiders Who Purchased US$1.42m Of RxSight Stock May Not Have Expected 12% Tumble - simplywall.st
Top 3 Health Care Stocks That Are Preparing To Pump This Quarter - Benzinga
RxSight: Favorable Risk/Reward Scenario with Strong Growth Prospects and Attractive Valuation - TipRanks
RxSight (NASDAQ:RXST) Sets New 12-Month Low After Earnings Miss - Defense World
Envestnet Asset Management Inc. Has $210,000 Position in RxSight, Inc. (NASDAQ:RXST) - Defense World
RxSight, Inc. Reports Strong Q1 2025 Revenue Growth - TipRanks
RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Rxsight Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: RxSight reports Q1 2025 earnings beat, stock rises 6.67% - Investing.com Nigeria
RxSight, Inc. (RXST) Tops Q1 EPS by 17c - StreetInsider
RxSight, Inc. Reports First Quarter 2025 Financial Results - The Manila Times
RxSight, Inc. Reports 28% Revenue Growth in Q1 2025, Highlights Strong Demand for Light Adjustable Lenses - Nasdaq
In the Green: RxSight Inc (RXST) Closes at 13.95, Up/Down -4.71 from Previous Day - DWinneX
RxSight, Inc. (NASDAQ:RXST) Shares Sold by First Trust Advisors LP - Defense World
RxSight’s Earnings Call: Growth Amid Challenges - TipRanks
RxSight (RXST) Expected to Announce Earnings on Wednesday - Defense World
How to Take Advantage of moves in (RXST) - news.stocktradersdaily.com
Prepare Yourself for Liftoff: RxSight Inc (RXST) - Sete News
RxSight Inc (RXST)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - DWinneX
RxSight Inc (RXST) is a good investment, but the stock may be undervalued - uspostnews.com
RxSight, Inc. to Present at the Bank of America Healthcare Conference - The Manila Times
RxSight, Inc. to Present at Bank of America Healthcare Conference on May 14, 2025 - Nasdaq
RxSight Brings Latest Cataract Surgery Innovation Updates to Major Healthcare Conference - Stock Titan
RxSight, Inc. (RXST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
Piper Sandler gives a Neutral recommendation for RxSight Inc (RXST) - knoxdaily.com
Russell Investments Group Ltd. Sells 94,412 Shares of RxSight, Inc. (NASDAQ:RXST) - Defense World
JPMorgan Chase & Co. Reduces Stake in RxSight, Inc. (NASDAQ:RXST) - Defense World
RxSight, Inc. (NASDAQ:RXST) Given Average Recommendation of “Hold” by Brokerages - Defense World
Finanzdaten der Rxsight Inc-Aktie (RXST)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):